Long-term follow-up after bioresorbable vascular scaffold
implantation in STEMI patients: PRAGUE-19 study update

J 2016

Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Robert PETR et al.

Základní údaje

Originální název

Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update

Autoři

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Robert PETR; Martin HAJSL; Jiří JARKOVSKÝ ; Libor LISA; Tomáš BUDĚŠÍNSKÝ a Petr WIDIMSKÝ

Vydání

EuroIntervention, Toulouse, Europa Edition, 2016, 1774-024X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Francie

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 5.193

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/16:00090040

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

bioresorbable vascular scaffold; long-term follow-up; optical coherence tomography; ST-elevation myocardial infarction

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 4. 8. 2016 10:15, Ing. Mgr. Věra Pospíšilíková

Anotace

V originále

Aims: Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing. This study evaluates longterm outcome in STEMI patients with implanted BVS. Methods and results: The PRAGUE-19 study is an academic study enrolling consecutive STEMI patients with the intention to implant BVS. A total of 580 STEMI patients were screened between December 2012 and March 2015; 117 patients fulfilled entry criteria and BVS was successfully implanted in 114 (97%) of them. The primary combined clinical endpoint (death, reinfarction or target vessel revascularisation) occurred in 11.5% during the mean follow-up period of 730±275 days with overall mortality of 4.4%. Definite scaffold thrombosis occurred in two patients in the early phase after BVS implantation; there was no late thrombosis. Quantitative coronary angiography (10 patients) at three years demonstrated late lumen loss of 0.2±0.33 mm and optical coherence tomography showed minimal lumen area of 5.3±1.37 mm2 and neointimal hyperplasia area of 2.9±0.48 mm2. BVS struts were still visible at three years and 99.4% of them were well apposed and covered. Conclusions: Encouraging clinical and imaging results after BVS implantation in STEMI patients persist during long-term follow-up.

Citovat

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Robert PETR; Martin HAJSL; Jiří JARKOVSKÝ; Libor LISA; Tomáš BUDĚŠÍNSKÝ a Petr WIDIMSKÝ. Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update. EuroIntervention. Toulouse: Europa Edition, 2016, roč. 12, č. 1, s. 23-29. ISSN 1774-024X. Dostupné z: https://doi.org/10.4244/EIJV12I1A5.

@article{1346044,
   author = {Toušek, Petr and Kočka, Viktor and Malý, Martin and Kozel, Martin and Petr, Robert and Hajsl, Martin and Jarkovský, Jiří and Lisa, Libor and Buděšínský, Tomáš and Widimský, Petr},
   article_location = {Toulouse},
   article_number = {1},
   doi = {https://doi.org/10.4244/EIJV12I1A5},
   keywords = {bioresorbable vascular scaffold; long-term follow-up; optical coherence tomography; ST-elevation myocardial infarction},
   language = {eng},
   issn = {1774-024X},
   journal = {EuroIntervention},
   title = {Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update},
   volume = {12},
   year = {2016}
}

TY  - JOUR
ID  - 1346044
AU  - Toušek, Petr - Kočka, Viktor - Malý, Martin - Kozel, Martin - Petr, Robert - Hajsl, Martin - Jarkovský, Jiří - Lisa, Libor - Buděšínský, Tomáš - Widimský, Petr
PY  - 2016
TI  - Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update
JF  - EuroIntervention
VL  - 12
IS  - 1
SP  - 23-29
EP  - 23-29
PB  - Europa Edition
SN  - 1774024X
KW  - bioresorbable vascular scaffold
KW  - long-term follow-up
KW  - optical coherence tomography
KW  - ST-elevation myocardial infarction
N2  - Aims: Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing. This study evaluates longterm outcome in STEMI patients with implanted BVS. Methods and results: The PRAGUE-19 study is an academic study enrolling consecutive STEMI patients with the intention to implant BVS. A total of 580 STEMI patients were screened between December 2012 and March 2015; 117 patients fulfilled entry criteria and BVS was successfully implanted in 114 (97%) of them. The primary combined clinical endpoint (death, reinfarction or target vessel revascularisation) occurred in 11.5% during the mean follow-up period of 730±275 days with overall mortality of 4.4%. Definite scaffold thrombosis occurred in two patients in the early phase after BVS implantation; there was no late thrombosis. Quantitative coronary angiography (10 patients) at three years demonstrated late lumen loss of 0.2±0.33 mm and optical coherence tomography showed minimal lumen area of 5.3±1.37 mm2 and neointimal hyperplasia area of 2.9±0.48 mm2. BVS struts were still visible at three years and 99.4% of them were well apposed and covered. Conclusions: Encouraging clinical and imaging results after BVS implantation in STEMI patients persist during long-term follow-up.
ER  -

TOUŠEK, Petr; Viktor KOČKA; Martin MALÝ; Martin KOZEL; Robert PETR; Martin HAJSL; Jiří JARKOVSKÝ; Libor LISA; Tomáš BUDĚŠÍNSKÝ a Petr WIDIMSKÝ. Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update. \textit{EuroIntervention}. Toulouse: Europa Edition, 2016, roč.~12, č.~1, s.~23-29. ISSN~1774-024X. Dostupné z: https://doi.org/10.4244/EIJV12I1A5.

Přehled o publikaci